Loren G Fong

Title: Loren G Fong: Innovator in Hypertriglyceridemia Treatment

Introduction

Loren G Fong is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hypertriglyceridemia. His innovative approach has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

Loren G Fong holds a patent for "Methods and compositions for treating hypertriglyceridemia." This application describes novel therapeutic strategies for treating patients with hypertriglyceridemia and/or chylomicronemia based on the presence of GPIHBP1 autoantibodies. It was unexpectedly found that autoantibodies to GPIHBP1, a GPI anchored protein of capillary endothelial cells that shuttles lipoprotein lipase to its site of action in the capillary lumen, were present in patients with hypertriglyceridemia. The autoantibodies block the binding of lipoprotein lipase (LPL) to GPIHBP1. Patients having hypertriglyceridemia and/or chylomicronemia and also having GPIHBP1 autoantibodies may be treated with a therapeutically effective amount of an immunosuppressive treatment and/or GPIHBP1 activator. Loren G Fong has 1 patent to his name.

Career Highlights

Loren G Fong is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its innovative approach to treating complex medical conditions.

Collaborations

Loren has collaborated with esteemed colleagues such as Anne P Beigneux and Katsuyuki Nakajima, contributing to the advancement of medical research and treatment strategies.

Conclusion

Loren G Fong's contributions to the treatment of hypertriglyceridemia highlight his role as an innovator in the medical field. His patent and ongoing research efforts are paving the way for new therapeutic strategies that could benefit many patients.